GUELPH, ON, Sept. 15 /CNW/ - BIOREM Inc. ("Biorem" or "the Company") (TSX-V: BRM) announced today that it has been awarded an advanced biofiltration project valued at $3.4 million. Under the terms of the agreement, Biorem will supply a biofiltration system ("the System") to remove volatile organic compounds ("VOC") and odorous emissions at a municipal organics processing facility located in Southern Ontario. The system is expected to treat approximately 155,000 cubic meters of complex contaminated air sources per hour and has been specifically designed to bring emissions at the processing facility to a level that will meet stringent odor guidelines set out by the Ontario Ministry of the Environment. These guidelines ensure that only one odor unit per cubic meter of air is at the property boundary.
"Understanding how odor and VOC emissions result from organic waste processing is a key element in developing solutions such as the one in Southern Ontario. Advanced research and product development have enabled Biorem to treat an array of industrial emissions particularly those in very sensitive, high profile applications," said Peter Bruijns, President and CEO. "Developing air emission control systems for facilities utilizing sustainable processes has created an important source of revenue for Biorem."
About BIOREM Inc.
BIOREM designs and manufactures air emission control systems, including biofiltration and biotrickling systems that safely remove harmful contaminants such as Hydrogen Sulfide, Reduced Sulfur compounds, and VOC's from the air. Our systems are environmentally friendly, clean and sustainable all the while reducing greenhouse gas emissions. With more than 600 installed systems worldwide, continued extensive research efforts and over 15 years of experience, BIOREM not only offers state of the art technology based products but also peace of mind for municipalities and industrial companies and their surrounding communities. Additional information on BIOREM is available at our web site at www.biorem.biz.
Neither TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
This press release contains forward-looking statements based on current expectations. These forward-looking statements contain various risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties about the Company's business are more fully discussed in the disclosure materials, financial statements and MD&A filed with the securities regulatory authorities in Canada on www.sedar.com
"Order Bookings" and "Order Backlog" do not have any standardized meaning prescribed by Canadian generally accepted accounting principles ("GAAP") and may not be comparable to measures presented by other companies.
Order Bookings and Order Backlog are non-GAAP measures that the Company uses to evaluate its sales performance. Order Bookings are those binding contracts that the Company enters into with a third party for the delivery of our products or services. As Order Bookings are received, the contract value (before any associated sales taxes) is included in the Order Backlog. The Order Backlog is reduced by the revenue that is recognized on each project.
SOURCE BIOREM Inc.
For further information: For further information: Ed Corbett, Chief Financial Officer, BIOREM Technologies Inc., firstname.lastname@example.org, Tel: (519) 767-9100 x275; Adriana Braczek, Investor Relations, The Equicom Group Inc., email@example.com, Tel: (416) 815-0700 x240